This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (129)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Women's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic

The Women’s Health Study: A Randomized Controlled Trial

Nancy R. Cook, ScD; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD; David Gordon, MA; Paul M Ridker, MD; JoAnn E. Manson, MD, DrPH; Charles H. Hennekens, MD, DrPH; Julie E. Buring, ScD

JAMA. 2005;294:47-55.

Context  Basic research and observational evidence as well as results from trials of colon polyp recurrence suggest a role for aspirin in the chemoprevention of cancer.

Objective  To examine the effect of aspirin on the risk of cancer among healthy women.

Design, Setting, and Participants  In the Women’s Health Study, a randomized 2 x 2 factorial trial of aspirin and vitamin E conducted between September 1992 and March 2004, 39 876 US women aged at least 45 years and initially without previous history of cancer, cardiovascular disease, or other major chronic illness were randomly assigned to receive either aspirin or aspirin placebo and followed up for an average of 10.1 years.

Intervention  A dose of 100 mg of aspirin (n=19 934) or aspirin placebo (n=19 942) administered every other day.

Main Outcome Measures  Confirmed newly diagnosed invasive cancer at any site, except for nonmelanoma skin cancer. Incidence of breast, colorectal, and lung cancer were secondary end points.

Results  No effect of aspirin was observed on total cancer (n = 2865; relative risk [RR], 1.01; 95% confidence interval [CI], 0.94-1.08; P = .87), breast cancer (n = 1230; RR, 0.98; 95% CI, 0.87-1.09; P = .68), colorectal cancer (n = 269; RR, 0.97; 95% CI, 0.77-1.24; P = .83), or cancer of any other site, with the exception of lung cancer for which there was a trend toward reduction in risk (n = 205; RR, 0.78; 95% CI, 0.59-1.03; P = .08). There was also no reduction in cancer mortality either overall (n = 583; RR, 0.95; 95% CI, 0.81-1.11; P = .51) or by site, except for lung cancer mortality (n = 140; RR, 0.70; 95% CI, 0.50-0.99; P = .04). No evidence of differential effects of aspirin by follow-up time or interaction with vitamin E was found.

Conclusions  Results from this large-scale, long-term trial suggest that alternate day use of low-dose aspirin (100 mg) for an average 10 years of treatment does not lower risk of total, breast, colorectal, or other site-specific cancers. A protective effect on lung cancer or a benefit of higher doses of aspirin cannot be ruled out.

Author Affiliations: Divisions of Preventive Medicine (Drs Cook, Lee, Gaziano, Ridker, Manson, and Buring, and Mr Gordon), Cardiovascular Medicine (Drs Gaziano and Ridker), and Aging (Drs Gaziano and Buring), Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Epidemiology, Harvard School of Public Health, Boston (Drs Cook, Lee, Ridker, Manson, and Buring); Veterans Affairs Boston Healthcare System (Dr Gaziano); Department of Ambulatory Care and Prevention, Harvard Medical School, Boston (Dr Buring); and the Departments of Medicine and Epidemiology and Public Health, University of Miami School of Medicine, Miami, Fla, and Department of Biomedical Science, Center of Excellence, Florida Atlantic University, Boca Raton (Dr Hennekens).

RELATED ARTICLES

Low-Dose Aspirin and Vitamin E: Challenges and Opportunities in Cancer Prevention
Eric J. Jacobs and Michael J. Thun
JAMA. 2005;294(1):105-106.
EXTRACT | FULL TEXT  

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Caffeine Consumption and the Risk of Breast Cancer in a Large Prospective Cohort of Women
Ishitani et al.
Arch Intern Med 2008;168:2022-2031.
ABSTRACT | FULL TEXT  

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2008;118:993-1001.
ABSTRACT | FULL TEXT  

Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women
Wang et al.
Am. J. Clin. Nutr. 2008;88:747-754.
ABSTRACT | FULL TEXT  

Measures of Obesity and Cardiovascular Risk Among Men and Women
Gelber et al.
J Am Coll Cardiol 2008;52:605-615.
ABSTRACT | FULL TEXT  

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint
Jankowski and Hunt
Cancer Epidemiol. Biomarkers Prev. 2008;17:1858-1861.
ABSTRACT | FULL TEXT  

Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
Suk Danik et al.
J Am Coll Cardiol 2008;52:124-131.
ABSTRACT | FULL TEXT  

Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point
Leshno et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1558-1561.
FULL TEXT  

Use of Common Medications and Breast Cancer Risk
Moysich et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1564-1595.
ABSTRACT | FULL TEXT  

Analgesic Drug Use and Risk of Epithelial Ovarian Cancer
Hannibal et al.
Am J Epidemiol 2008;167:1430-1437.
ABSTRACT | FULL TEXT  

Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study
Kurth et al.
Thorax 2008;63:514-518.
ABSTRACT | FULL TEXT  

A Prospective Study of Multivitamin Supplement Use and Risk of Breast Cancer
Ishitani et al.
Am J Epidemiol 2008;167:1197-1206.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women
Terry et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1088-1095.
ABSTRACT | FULL TEXT  

The Joint Effects of Physical Activity and Body Mass Index on Coronary Heart Disease Risk in Women
Weinstein et al.
Arch Intern Med 2008;168:884-890.
ABSTRACT | FULL TEXT  

MDM2 SNP309 Is Associated with Endometrial Cancer Risk
Terry et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:983-986.
ABSTRACT | FULL TEXT  

Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer
Viswanathan et al.
Cancer Res. 2008;68:2507-2513.
ABSTRACT | FULL TEXT  

Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women
Lin et al.
Am. J. Clin. Nutr. 2008;87:734-743.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
Hudson et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:680-687.
ABSTRACT | FULL TEXT  

Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women
Ridker et al.
Clin. Chem. 2008;54:249-255.
ABSTRACT | FULL TEXT  

Generalizability of the Results of Randomized Trials
Weiss et al.
Arch Intern Med 2008;168:133-135.
FULL TEXT  

Plasma Androgen Concentrations and Risk of Incident Ovarian Cancer
Tworoger et al.
Am J Epidemiol 2008;167:211-218.
ABSTRACT | FULL TEXT  

Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women
Van Dyke et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:148-157.
ABSTRACT | FULL TEXT  

Dietary Carotenoids, Vitamins C and E, and Risk of Cataract in Women: A Prospective Study
Christen et al.
Arch Ophthalmol 2008;126:102-109.
ABSTRACT | FULL TEXT  

Plasma Cysteinylglycine Levels and Breast Cancer Risk in Women
Lin et al.
Cancer Res. 2007;67:11123-11127.
ABSTRACT | FULL TEXT  

Nonsteroidal Antiinflammatory Drugs and Breast Cancer Risk: The Multiethnic Cohort
Gill et al.
Am J Epidemiol 2007;166:1150-1158.
ABSTRACT | FULL TEXT  

Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms
Mora et al.
Circulation 2007;116:2110-2118.
ABSTRACT | FULL TEXT  

Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism: A Randomized Trial
Glynn et al.
ANN INTERN MED 2007;147:525-533.
ABSTRACT | FULL TEXT  

Commentary: Preventing colorectal cancer with aspirin what next?
Logan
Int J Epidemiol 2007;0:dym204v1-dym204.
FULL TEXT  

Commentary: Aspirin and colorectal cancer an epidemiological success story
Flossmann and Rothwell
Int J Epidemiol 2007;36:962-965.
FULL TEXT  

Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women's Health Study
Glynn et al.
Circulation 2007;116:1497-1503.
ABSTRACT | FULL TEXT  

Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings
Kirsh et al.
Am J Epidemiol 2007;166:709-716.
ABSTRACT | FULL TEXT  

Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gray et al.
Chest 2007;132:56S-68S.
ABSTRACT | FULL TEXT  

Insulin-like Growth Factors and Ovarian Cancer Risk: A Nested Case-Control Study in Three Cohorts
Tworoger et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1691-1695.
ABSTRACT | FULL TEXT  

Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
Bardia et al.
JNCI J Natl Cancer Inst 2007;99:881-889.
ABSTRACT | FULL TEXT  

C-Reactive Protein and Risk of Breast Cancer
Zhang et al.
JNCI J Natl Cancer Inst 2007;99:890-894.
ABSTRACT | FULL TEXT  

Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women
Lin et al.
Arch Intern Med 2007;167:1050-1059.
ABSTRACT | FULL TEXT  

Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical Trials: A Randomized Study of Cardiovascular Prevention Trials
Ding et al.
Arch Intern Med 2007;167:905-912.
ABSTRACT | FULL TEXT  

Low dose aspirin and cognitive function in the women's health study cognitive cohort
Kang et al.
BMJ 2007;334:987-987.
ABSTRACT | FULL TEXT  

More Aspirin for Less Cancer?
Martinez and Greenberg
JNCI J Natl Cancer Inst 2007;99:582-583.
FULL TEXT  

Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer
Tworoger et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:783-788.
ABSTRACT | FULL TEXT  

Oral Contraceptives, Reproductive Factors, and Risk of Colorectal Cancer among Women in a Prospective Cohort Study
Lin et al.
Am J Epidemiol 2007;165:794-801.
ABSTRACT | FULL TEXT  

Can Aspirin Keep Mortality at Bay?
Baron
Arch Intern Med 2007;167:535-536.
FULL TEXT  

Long-term Aspirin Use and Mortality in Women
Chan et al.
Arch Intern Med 2007;167:562-572.
ABSTRACT | FULL TEXT  

Alcohol Consumption and Breast Cancer Risk in the Women's Health Study
Zhang et al.
Am J Epidemiol 2007;165:667-676.
ABSTRACT | FULL TEXT  

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force*
ANN INTERN MED 2007;146:361-364.
ABSTRACT | FULL TEXT  

The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Dube et al.
ANN INTERN MED 2007;146:365-375.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Rostom et al.
ANN INTERN MED 2007;146:376-389.
ABSTRACT | FULL TEXT  

Use of Oral Conjugated Estrogen Alone and Risk of Breast Cancer
Zhang et al.
Am J Epidemiol 2007;165:524-529.
ABSTRACT | FULL TEXT  

Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women
Sesso et al.
Hypertension 2007;49:304-310.
ABSTRACT | FULL TEXT  

C-Reactive Protein in the Prediction of Rheumatoid Arthritis in Women
Shadick et al.
Arch Intern Med 2006;166:2490-2494.
ABSTRACT | FULL TEXT  

Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis
Larsson et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2561-2564.
ABSTRACT | FULL TEXT  

Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study.
Hayes et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2226-2231.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study.
Mahipal et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1785-1790.
ABSTRACT | FULL TEXT  

Total magnesium intake and colorectal cancer incidence in women.
Lin et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2006-2009.
FULL TEXT  

Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik et al.
JAMA 2006;296:1363-1370.
ABSTRACT | FULL TEXT  

Plasma Lycopene, Other Carotenoids, and the Risk of Type 2 Diabetes in Women
Wang et al.
Am J Epidemiol 2006;164:576-585.
ABSTRACT | FULL TEXT  

The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women
Allison et al.
Am J Epidemiol 2006;164:567-575.
ABSTRACT | FULL TEXT  

Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty and Potter
NEJM 2006;355:950-952.
FULL TEXT  

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2006;114:381-387.
ABSTRACT | FULL TEXT  

Healthy lifestyle and the risk of stroke in women.
Kurth et al.
Arch Intern Med 2006;166:1403-1409.
ABSTRACT | FULL TEXT  

Biorepositories: Let's Not Lose What We Have So Carefully Gathered!
Goodman et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:599-601.
FULL TEXT  

Association of Physical Activity and Body Mass Index With Novel and Traditional Cardiovascular Biomarkers in Women
Mora et al.
JAMA 2006;295:1412-1419.
ABSTRACT | FULL TEXT  

A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women.
Lin et al.
Cancer Res. 2006;66:2869-2875.
ABSTRACT | FULL TEXT  

Low dose aspirin did not prevent cancer in healthy women
Rees Willett
Evid. Based Med. 2006;11:10-10.
FULL TEXT  

Aspirin Has A Gender-Dependent Impact on Antiinflammatory 15-Epi-Lipoxin A4 Formation: A Randomized Human Trial
Chiang et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:e14-e17.
ABSTRACT | FULL TEXT  

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology
Herbst et al.
JCO 2006;24:190-205.
ABSTRACT | FULL TEXT  

Long-term Use of Aspirin and Risk of Colorectal Cancer--Reply
Chan and Fuchs
JAMA 2005;294:3090-3091.
FULL TEXT  

Do ASA and NSAIDs reduce the risk of colorectal cancer?
Murray
CMAJ 2005;173:1159-1160.
FULL TEXT  

Low dose aspirin doesn't lower women's cancer risk
BMJ 2005;331:.
FULL TEXT  

Antioxidants to Prevent Cancer and Heart Disease?
JWatch Women's Health 2005;2005:4-4.
FULL TEXT  

Little Benefit to Women from Aspirin or Vitamin E
Journal Watch Dermatology 2005;2005:6-6.
FULL TEXT  

Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan et al.
JAMA 2005;294:914-923.
ABSTRACT | FULL TEXT  

New Women's Health Study Data on Vitamin E and Aspirin
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT  

Little Benefit to Aspirin or Vitamin E in Women
JWatch General 2005;2005:1-1.
FULL TEXT  

Non-HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women
Ridker et al.
JAMA 2005;294:326-333.
ABSTRACT | FULL TEXT  

Low-Dose Aspirin and Vitamin E: Challenges and Opportunities in Cancer Prevention
Jacobs and Thun
JAMA 2005;294:105-106.
FULL TEXT